Revvity Inc. $RVTY Shares Sold by Parallel Advisors LLC

Parallel Advisors LLC lessened its holdings in Revvity Inc. (NYSE:RVTY) by 18.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 637 shares of the company’s stock after selling 140 shares during the quarter. Parallel Advisors LLC’s holdings in Revvity were worth $62,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. HB Wealth Management LLC boosted its holdings in Revvity by 4.8% in the first quarter. HB Wealth Management LLC now owns 2,494 shares of the company’s stock worth $264,000 after acquiring an additional 114 shares in the last quarter. RDA Financial Network boosted its holdings in Revvity by 3.6% in the first quarter. RDA Financial Network now owns 3,331 shares of the company’s stock worth $352,000 after acquiring an additional 115 shares in the last quarter. Farther Finance Advisors LLC boosted its holdings in Revvity by 21.2% in the first quarter. Farther Finance Advisors LLC now owns 796 shares of the company’s stock worth $83,000 after acquiring an additional 139 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its holdings in Revvity by 25.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 694 shares of the company’s stock worth $73,000 after acquiring an additional 140 shares in the last quarter. Finally, Banque Transatlantique SA boosted its holdings in Revvity by 19.4% in the first quarter. Banque Transatlantique SA now owns 925 shares of the company’s stock worth $90,000 after acquiring an additional 150 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Wall Street Zen downgraded Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 3rd. Evercore ISI decreased their target price on Revvity from $116.00 to $115.00 and set an “outperform” rating for the company in a report on Tuesday, July 8th. Bank of America cut their price target on shares of Revvity from $110.00 to $99.00 and set a “buy” rating on the stock in a report on Monday. Raymond James Financial reissued an “outperform” rating and set a $115.00 price target (down from $120.00) on shares of Revvity in a research report on Tuesday, July 29th. Finally, Stifel Nicolaus dropped their price objective on shares of Revvity from $120.00 to $110.00 and set a “hold” rating on the stock in a report on Tuesday, July 29th. Ten investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $119.29.

Revvity Trading Down 1.7%

Shares of NYSE:RVTY opened at $83.09 on Friday. Revvity Inc. has a 12-month low of $81.36 and a 12-month high of $129.50. The company has a market capitalization of $9.64 billion, a PE ratio of 35.21, a PEG ratio of 2.82 and a beta of 0.94. The business has a 50 day moving average of $89.13 and a two-hundred day moving average of $94.47. The company has a current ratio of 3.33, a quick ratio of 2.75 and a debt-to-equity ratio of 0.43.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.14 by $0.04. Revvity had a return on equity of 7.66% and a net margin of 10.19%.The company had revenue of $720.28 million during the quarter, compared to the consensus estimate of $711.26 million. During the same period in the previous year, the company posted $1.22 earnings per share. Revvity’s revenue for the quarter was up 4.1% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. As a group, analysts forecast that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 17th will be given a $0.07 dividend. The ex-dividend date is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s payout ratio is 11.86%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.